Nuvation Bio Inc.
Nuvation Bio Inc.
Share · US67080N1191 · NUVB-WT (XNYS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - - - -

Company Profile for Nuvation Bio Inc. Share

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Company Data

Name Nuvation Bio Inc.
Company Nuvation Bio Inc.
Symbol NUVB-WT
Website http://www.nuvationbio.com
Primary Exchange XNYS NYSE
ISIN US67080N1191
Asset Class Share
Sector Healthcare
Industry Biotechnology
Market Capitalization 816 Mio
Country United States of America
Currency USD
Employees 0,2 T
Address , New York City

Ticker Symbols

Name Symbol
NYSE NUVB-WT

More Shares

Investors who Nuvation Bio Inc. hold also have the following shares in their portfolio:
Epigenomics AG
Epigenomics AG Share
ITALIEN 24/32 FLR
ITALIEN 24/32 FLR Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025